Geographic · Total long-lived assets

Rest-of-World — Total long-lived assets

United Therapeutics Rest-of-World — Total long-lived assets increased by 35.0% to $15.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 35.0%, from $11.70M to $15.80M.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2020
Last reportedQ4 2025
Rolls up toPP&E (Net)

How to read this metric

An increase suggests expanding international operational capacity or investment in foreign market infrastructure, while a decrease may indicate asset divestiture or depreciation exceeding new capital investment.

Detailed definition

This metric represents the total value of non-current assets held by the company within its international geographic seg...

Peer comparison

Peers in the pharmaceutical industry typically report this as part of geographic segment disclosures, often correlated with the maturity of international distribution networks.

Metric ID: uthr_segment_rest_of_world_total_long_lived_assets

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$12.80M$12.60M$12.00M$11.70M$15.80M
QoQ Change-1.6%-4.8%-2.5%+35.0%
YoY Change-1.6%-4.8%-2.5%+35.0%
Range$11.70M$15.80M
CAGR+23.4%
Avg YoY Growth+6.6%
Median YoY Growth-2.0%

Frequently Asked Questions

What is United Therapeutics's rest-of-world — total long-lived assets?
United Therapeutics (UTHR) reported rest-of-world — total long-lived assets of $15.80M in Q4 2025.
How has United Therapeutics's rest-of-world — total long-lived assets changed year-over-year?
United Therapeutics's rest-of-world — total long-lived assets increased by 35.0% year-over-year, from $11.70M to $15.80M.
What does rest-of-world — total long-lived assets mean?
The total value of long-term assets, such as property and intangible rights, held by the company in international markets.